3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
5
Neoplasms
4
Colorectal Neoplasms
4
Head and Neck Neoplasms
2
Diabetes Mellitus
2
Chronic Disease
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Sleep Wake Disorders
1
Sleep Initiation and Maintenance Disorders
1
Pulmonary Disease, Chronic Obstructive
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Obesity
1
Multiple Myeloma
1
Mucositis
1
Motor Activity
1
Lymphoma
1
Lymphoid Interstitial Pneumonia
1
Lymphedema
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hypertension
1
Coronary Disease
1
Cardiovascular Diseases
1
Interventions
Ipilimumab
98
pembrolizumab
84
Nivolumab
82
aldesleukin
51
Cyclophosphamide
49
Interleukin-2
38
fludarabine phosphate
31
Vemurafenib
31
Dacarbazine
31
dabrafenib
29
trametinib
28
Temozolomide
26
fludarabine
25
CTLA-4 Antigen
18
Bevacizumab
18
Radiosurgery
15
Paclitaxel
15
Carboplatin
14
encorafenib
13
binimetinib
13
Introns
13
talimogene laherparepvec
12
Radiotherapy
12
Interferon alpha-2
12
spartalizumab
11
cobimetinib
10
atezolizumab
10
sargramostim
9
peginterferon alfa-2b
9
montanide ISA 51
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Melanoma
×
Methods
×
Clear all
No trials found.